Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Mineralys Therapeutics (MLYS)

Mineralys Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MLYS
DateTimeSourceHeadlineSymbolCompany
14/02/202511:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MLYSMineralys Therapeutics Inc
12/02/202512:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
12/02/202512:00GlobeNewswire Inc.Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
05/02/202521:05GlobeNewswire Inc.Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025NASDAQ:MLYSMineralys Therapeutics Inc
04/02/202513:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
04/02/202513:00GlobeNewswire Inc.Mineralys Therapeutics Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and AlbuminuriaNASDAQ:MLYSMineralys Therapeutics Inc
08/01/202513:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
08/01/202513:00GlobeNewswire Inc.Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
13/11/202421:27Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MLYSMineralys Therapeutics Inc
12/11/202421:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MLYSMineralys Therapeutics Inc
12/11/202413:36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
12/11/202413:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
11/11/202421:05GlobeNewswire Inc.Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
05/11/202421:05GlobeNewswire Inc.Mineralys Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:MLYSMineralys Therapeutics Inc
30/10/202412:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
30/10/202412:00GlobeNewswire Inc.Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
22/10/202412:00GlobeNewswire Inc.Mineralys to Host Virtual KOL Event on the Unmet Medical Need in Uncontrolled and Resistant Hypertension, and Lorundrostat as a Potential Treatment on October 30, 2024NASDAQ:MLYSMineralys Therapeutics Inc
25/09/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
25/09/202412:00GlobeNewswire Inc.Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of HypertensionNASDAQ:MLYSMineralys Therapeutics Inc
13/08/202420:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MLYSMineralys Therapeutics Inc
13/08/202420:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
13/08/202420:05GlobeNewswire Inc.Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:MLYSMineralys Therapeutics Inc
05/08/202420:05GlobeNewswire Inc.Mineralys Therapeutics to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024NASDAQ:MLYSMineralys Therapeutics Inc
17/06/202420:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
17/06/202420:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202412:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
14/06/202412:00GlobeNewswire Inc.Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of DirectorsNASDAQ:MLYSMineralys Therapeutics Inc
10/06/202420:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
31/05/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MLYSMineralys Therapeutics Inc
23/05/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MLYSMineralys Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLYS